Gout increases diabetes risk, especially among women
by Bruce Sylvester: Gout is associated with an increased risk of developing type 2 diabetes, researchers reported on Oct 2, 2014 in the British Medical Journal/BMJ. And the… read more.
by Bruce Sylvester: Gout is associated with an increased risk of developing type 2 diabetes, researchers reported on Oct 2, 2014 in the British Medical Journal/BMJ. And the… read more.
by Bruce Sylvester – Compared with monotherapy with long-acting beta-agonists (LABAs), combination therapy with LABAs and inhaled corticosteroids (ICSs) among older adults with chronic obstructive pulmonary disease (COPD),… read more.
This webinar covers various topics including: Heart Failure definition, Epidemiology & Aetiology / NYHA classification / CHF treatment overview / Reviewing CHF patients. This webinar was initiated and… read more.
by Bruce Sylvester – Researchers report that metformin therapy, a treatment for type 2 diabetes, could induce a lowering thyroid-stimulating hormone (TSH) in patients with underactive thyroids (hypothyroidism)…. read more.
by Bruce Sylvester – Following heart attack, patients who undergo revascularization of all significantly blocked arteries achieve better outcomes than patients who undergo revascularization of the “culprit” artery… read more.
by Bruce Sylvester – Compared to no screening, flexible sigmoidoscopy screening has resulted in a reduced incidence of colorectal cancer and rate of death from colorectal cancer, researchers… read more.
by Thomas R. Collins – After evaluating data on 5 million adults in the UK, researchers concluded that an increasing body mass index (BMI) raises the odds of… read more.
by Bruce Sylvester – Ibrutinib has significantly outperformed ofatumumab as a second-line therapy for chronic lymphocytic leukemia (CLL), according to a Phase 3 study published on May 31,… read more.
by Bruce Sylvester: After 13 months of high-dose statin therapy, STEMI (ST Segment Elevation Myocardial Infarction) patients achieved significant reductions in coronary atherosclerosis, researchers reported on Sept. 2,… read more.
by Bruce Sylvester: Two intravenous doses of an iron supplement appears to cause heart failure patients with iron deficiency to achieve significant improvements in functional capacity, quality of… read more.
Report from the ESC Annual Congress by Bruce Sylvester: The investigational monoclonal antibody alirocumab, which significantly lowers cholesterol on top of regular statin therapy, also lowers the incidence… read more.
Report from the European Society of Cardiology Annual Congress in Barcelona by Bruce Sylvester – Results from the PARADIGM-HF trial, presented at ESC 2014 on August 30,2014 and… read more.
Advertisment